A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion

Makoto Shigeto1,2, Chae Young Cha3, Patrik Rorsman3

  • 1Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK. shigeto@med.kawasaki-m.ac.jp.

Journal of Molecular Medicine (Berlin, Germany)
|January 19, 2017
PubMed

Insights

Glucagon-like peptide-1 (GLP-1) at physiological concentrations stimulates insulin secretion via a novel protein kinase C (PKC) pathway, distinct from the established protein kinase A (PKA) pathway. This discovery offers insights into GLP-1

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Glucagon-like peptide-1 (GLP-1) is an endogenous hormone crucial for glucose regulation.
  • GLP-1 receptor agonists are established antidiabetic therapies.
  • The canonical cAMP-Epac2-PKA-KATP channel pathway is widely accepted for GLP-1-stimulated insulin secretion, based on high-concentration studies.

Purpose of the Study:

  • To review and contrast the signaling mechanisms of GLP-1 at physiological (pM) versus pharmacological (nM) concentrations.
  • To highlight the recently discovered PKA-independent pathway activated by physiological GLP-1 levels.
  • To explore how differential signaling might explain diverse GLP-1 functions.

Main Methods:

  • Review of recent in vitro studies on isolated islets and beta cells.
  • Analysis of GLP-1 effects at nanomolar (1-100 nM) and picomolar (1-10 pM) concentrations.
  • Investigation of signaling components including cAMP, PKA, PKC, PLC, Ca2+ channels, and KATP channels.

Main Results:

  • Physiological GLP-1 concentrations stimulate insulin secretion, depolarization, and Ca2+ influx independently of PKA and cAMP.
  • These low-concentration effects are mediated by PKC, GLP1R, PLC, and involve DAG elevation and altered Ca2+ and TRPM channel activity.
  • Pharmacological GLP-1 concentrations activate the canonical cAMP-PKA pathway.

Conclusions:

  • GLP-1 utilizes distinct intracellular signaling pathways at physiological and pharmacological concentrations.
  • The PKA-independent pathway activated by physiological GLP-1 is crucial for insulin secretion.
  • Understanding these differential pathways may elucidate GLP-1's diverse roles in the central nervous system and periphery.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.9K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K